In vivo biodistribution and physiologically based pharmacokinetic modeling of inhaled fresh and aged cerium oxide nanoparticles in rats

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1743-8977
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
In vivo biodistribution and physiologically based pharmacokinetic modeling of inhaled fresh and aged cerium oxide nanoparticles in rats ; volume:13 ; number:1 ; day:20 ; month:8 ; year:2016 ; pages:1-20 ; date:12.2015
Particle and fibre toxicology ; 13, Heft 1 (20.8.2016), 1-20, 12.2015

Urheber
Li, Dingsheng
Beteiligte Personen und Organisationen
Morishita, Masako
Wagner, James G.
Fatouraie, Mohammad
Wooldridge, Margaret
Eagle, W. Ethan
Barres, James
Carlander, Ulrika
Emond, Claude
Jolliet, Olivier
SpringerLink (Online service)

DOI
10.1186/s12989-016-0156-2
URN
urn:nbn:de:1111-201609177350
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:47 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Li, Dingsheng
  • Morishita, Masako
  • Wagner, James G.
  • Fatouraie, Mohammad
  • Wooldridge, Margaret
  • Eagle, W. Ethan
  • Barres, James
  • Carlander, Ulrika
  • Emond, Claude
  • Jolliet, Olivier
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution

Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution

Physiologically Based Pharmacokinetic Modelling of Inhaled Nemiralisib: Mechanistic Components for Pulmonary Absorption, Systemic Distribution, and Oral Absorption

Physiologically Based Pharmacokinetic Modelling of Inhaled Nemiralisib: Mechanistic Components for Pulmonary Absorption, Systemic Distribution, and Oral Absorption

Interspecies extrapolation by physiologically based pharmacokinetic modeling

Interspecies extrapolation by physiologically based pharmacokinetic modeling

Human physiologically based pharmacokinetic model for propofol

Human physiologically based pharmacokinetic model for propofol

Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations

Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations

Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling

Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling

Adapting physiologically-based pharmacokinetic models for machine learning applications

Adapting physiologically-based pharmacokinetic models for machine learning applications

Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances

Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances

Evaluation of the Potential for Drug-Drug Interactions with Inhaled Itraconazole Using Physiologically Based Pharmacokinetic Modelling, Based on Phase 1 Clinical Data

Evaluation of the Potential for Drug-Drug Interactions with Inhaled Itraconazole Using Physiologically Based Pharmacokinetic Modelling, Based on Phase 1 Clinical Data

Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference

Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference

A minimal physiologically based pharmacokinetic model for high-dose methotrexate

A minimal physiologically based pharmacokinetic model for high-dose methotrexate

Inhaled milrinone in cardiac surgical patients: pharmacokinetic and pharmacodynamic exploration

Inhaled milrinone in cardiac surgical patients: pharmacokinetic and pharmacodynamic exploration

Verbundene Objekte